Your browser doesn't support javascript.
loading
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.
Ladenstein, Ruth; Pötschger, Ulrike; Pearson, Andrew D J; Brock, Penelope; Luksch, Roberto; Castel, Victoria; Yaniv, Isaac; Papadakis, Vassilios; Laureys, Geneviève; Malis, Josef; Balwierz, Walentyna; Ruud, Ellen; Kogner, Per; Schroeder, Henrik; de Lacerda, Ana Forjaz; Beck-Popovic, Maja; Bician, Pavel; Garami, Miklós; Trahair, Toby; Canete, Adela; Ambros, Peter F; Holmes, Keith; Gaze, Mark; Schreier, Günter; Garaventa, Alberto; Vassal, Gilles; Michon, Jean; Valteau-Couanet, Dominique.
Afiliación
  • Ladenstein R; Children's Cancer Research Institute (CCRI)-S(2)IRP: Studies and Statistics for Integrated Research and Projects, Medical University, Vienna, Austria; St Anna Children's Hospital and Department of Paediatrics of the Medical University, Vienna, Austria. Electronic address: ruth.ladenstein@ccri.at.
  • Pötschger U; Children's Cancer Research Institute (CCRI)-S(2)IRP: Studies and Statistics for Integrated Research and Projects, Medical University, Vienna, Austria.
  • Pearson ADJ; Paediatric and Adolescent Drug Development Team, Oak Centre for Children and Young People, Institute of Cancer Research, Royal Marsden Hospital, Sutton, UK.
  • Brock P; Department Paediatric Oncology, Great Ormond Street Hospital, London, UK.
  • Luksch R; Dipartimento di Ematologia e Onco-ematologia Pediatrica, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Castel V; Pediatric Oncology Unit, Hospital Universitario y Politecnico La Fe, Valencia, Spain.
  • Yaniv I; Sackler Faculty of Medicine, Tel Aviv University, Schneider Children's Medical Center of Israel, Petach, Tikvah, Israel.
  • Papadakis V; Department of Paediatric Haematology-Oncology, Agia Sofia Children's Hospital Athens, Athens, Greece.
  • Laureys G; Department of Pediatric Hematology/Oncology and Stem Cell Transplantation University Hospital Ghent, Ghent, Belgium.
  • Malis J; Department of Pediatric Hematology and Oncology, University Hospital Motol, Prague, Czech Republic.
  • Balwierz W; Department of Pediatric Oncology and Hematology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland.
  • Ruud E; Department of Paediatric Medicine, Rikshospitalet, Oslo University Hospital, Oslo, Norway.
  • Kogner P; Department of Women's and Children's Health, Karolinska Institutet, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Schroeder H; Department of Pediatrics, Aarhus University Hospital Skejby, Aarhus, Denmark.
  • de Lacerda AF; Department of Paediatric and Adolescent Oncology, Portuguese Institute of Oncology, Lisbon, Portugal.
  • Beck-Popovic M; Department of Pediatrics and Pediatric Surgery, Pediatric Haematology Oncology Unit, University Hospital Lausanne, Lausanne, Switzerland.
  • Bician P; Clinic of Pediatric Oncology and Hematology, University Children's Hospital, Banska Bystrica, Slovakia.
  • Garami M; Second Department of Pediatrics, Semmelweis University, Budapest, Hungary.
  • Trahair T; Kids Cancer Centre, Sydney Children's Hospital, Randwick, NSW, Australia.
  • Canete A; Pediatric Oncology Unit, Hospital Universitario y Politecnico La Fe, Valencia, Spain.
  • Ambros PF; Children's Cancer Research Institute Department of Tumour Biology, Medical University, Vienna, Austria.
  • Holmes K; Department Paediatric Surgery, St Georges Hospital, London, UK.
  • Gaze M; Department of Oncology, University College Hospital, London, UK.
  • Schreier G; Center for Health and Bioresources, AIT Austrian Institute of Technology, Graz, Austria.
  • Garaventa A; Oncology Unit, Istituto Giannina Gaslini, Genoa, Italy.
  • Vassal G; Children and Adolescent Oncology Department, Gustave Roussy, Paris-Sud University, Paris, France.
  • Michon J; Children, Adolescent and Young Adults Department, Institut Curie, Paris, France.
  • Valteau-Couanet D; Children and Adolescent Oncology Department, Gustave Roussy, Paris-Sud University, Paris, France.
Lancet Oncol ; 18(4): 500-514, 2017 04.
Article en En | MEDLINE | ID: mdl-28259608
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Protocolos de Quimioterapia Combinada Antineoplásica / Neuroblastoma Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Óseas / Protocolos de Quimioterapia Combinada Antineoplásica / Neuroblastoma Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article Pais de publicación: Reino Unido